COPARIME: Pilot Study of a Target Detection of Malignant Melanoma
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4,118
- 试验地点
- 1
- 主要终点
- Prevalence ratios between those of the COPARIME cohort and those of the general population.
研究概览
简要总结
Melanoma is nowadays an important public health problem because its growing incidence. Mass screening for melanoma is not recommended worldwide because of its low cost-effectiveness. Nevertheless targeted screening for patients at high risk for melanoma is promoted. This study is designed to assess the effectiveness and the acceptability of a melanoma targeted screening of melanoma, to estimate the risk function to develop a melanoma among patients at high risk according to the SAMScore and to estimate the ratio cost/ efficacy of the melanoma targeted screening. A cohort of 7700 patients is carried out in 2 departments covered by a registry of cancers. The recruitment had began in April 2011. Patients assessed at high risk according to the SAMScore were proposed a skin examination by their GP every year.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients more than 18 years old,
- •consulting their GP,
- •assessed at risk for melanoma according to the SAMScore
- •signed the consent.
排除标准
- 未提供
结局指标
主要结局
Prevalence ratios between those of the COPARIME cohort and those of the general population.
时间窗: 5 years
Number of melanomas detected / Number of patients at high risk of melanoma defined by our selection tool.
次要结局
- Probability to develop a melanoma at one year.(1 years)
- Cost ratio for a screened melanoma.(5 years)